Stroke prevention: which drugs to use and when?

Area of Science:

• Neurology
• Cardiology
• Preventive Medicine

Background:

• Stroke remains a leading cause of disability and mortality worldwide.
• Effective prevention strategies are crucial for reducing stroke incidence.
• Current guidelines require updates based on recent clinical trial data.

Purpose of the Study:

• To review recent clinical trial findings on stroke prevention.
• To translate evidence into actionable therapeutic guidelines.
• To stratify recommendations based on patient subgroups.

Main Methods:

• Systematic review of clinical trials focusing on stroke prevention.
• Analysis of data stratified by prior cerebrovascular disease and atrial fibrillation status.
• Synthesis of findings to inform treatment recommendations.

Main Results:

• Aspirin demonstrates consistent, albeit modest, efficacy across patient subgroups with vascular disease.
• Oral anticoagulants are the optimal choice for patients with both atrial fibrillation and vascular risk factors.
• Distinguishing between patient groups is essential for tailored prevention strategies.

Conclusions:

• Therapeutic guidelines for stroke prevention should incorporate recent clinical trial evidence.
• Aspirin remains a first-line option for many patients with vascular disease.
• Personalized treatment, considering atrial fibrillation and risk factors, is key to optimal stroke prevention.